Source: Allergan near $66B buyout to escape Valeant, Ackman

Allergan is close to sealing a deal worth nearly $66 billion with Actavis and giving the slip to a hostile takeover bid from Valeant Pharmaceuticals and William Ackman's Pershing Square hedge fund.

Actavis, Pershing Square Capital Management, Valeant Pharmaceuticals, Allergan Inc.

News Well, Mergers & Acquisitions, Pharmaceuticals

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1u1h4kt